WO2020182860A1
|
|
Norovirus-like particles with improved stability
|
WO2019158653A1
|
|
Immunogenic composition and vaccine for generating an immune response to norovirus
|
EP3004359A1
|
|
Methods of modulating n-glycosylation site occupancy of plant-produced glycoproteins and recombinant glycoproteins
|
EP2777711A1
|
|
Her2/Neu cancer vaccine
|
AU2012320847A1
|
|
Nicotiana benthamiana plants deficient in fucosyltransferase activity
|
EP2551348A2
|
|
Production of galactosylated N-glycans in plants
|
EP2500035A1
|
|
Pharmaceutical formulation containing immunglobulin
|
EP2395087A1
|
|
System and method of modular cloning
|
AU2010262087A1
|
|
Nicotiana benthamiana plants deficient in xylosyltransferase activity
|
EP2175018A1
|
|
Process of clean cloning
|
EP2100961A1
|
|
Method of protease production in plants
|
EP2006387A1
|
|
Translation control elements for plastid transformation
|
CN101454456A
|
|
Plant virus-based inducible expression system
|
EP2029751A1
|
|
Plant virus-based inducible expression system
|
EP1897953A1
|
|
Potexvirus-derived replicon
|
EP2184363A1
|
|
RNA virus-derived plant expression system
|
AU2002314021B2
|
|
Amplification vectors based on trans-splicing
|
US2006174365A1
|
|
Process of producing environmentally safe transgenic organisms
|
DE10121283A1
|
|
Methods and vectors for amplification or expression of desired nucleic acid sequences in plants
|
EP1017834A1
|
|
Methods for coexpression of more than one gene using at least one internal ribosome entry site (ires)
|